Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

NCT00704522 · clinicaltrials.gov ↗

COMPLETED

Status

601

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic
Hepacivirus

Interventions

BIOLOGICAL: Peginterferon alfa-2b (SCH 54031)
DRUG: Ribavirin (SCH 18908)
BEHAVIORAL: Patient assistance program

Sponsor

Merck Sharp & Dohme LLC